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Insecticides and pesticides are increasingly becoming the most common agents of poisoning in children [1]. Rodenticides are among the most toxic substances regularly found in 
homes. There are no studies on domestic rodenticide poisoning in 
children. It is imperative to know the different types of rodenticides 
available, their chemical composition and toxicity symptoms. 
Mortality rate as high as 77% has been reported [2]. Most of the 
studies on rodenticide poisoning included mainly adults [2-4]. 
Poisoning in adults and children are not the same. In adults, 
ingestions are usually suicidal in intent with ingestion of large 
quantities compared to children where poisoning is commonly 
accidental and quantity ingested is also often not known. Very 
small quantity ingestions can occur which may manifest with only 
subtle symptoms initially. This study was conducted to study the 
clinical presentation, risk factors for mortality and early markers 
of toxicity of rodenticide poisoning in children. 
METHODS
This observational, hospital based study was conducted at 
pediatric intensive care unit of a Government Medical College, 
Thiruvananthapuram from October 2014 to October 2016. All 
children <12 years of age, admitted with a history of ingestion of 
rat poison during the study period, were included in the study after 
obtaining ethical committee clearance. Clinical history was taken 
in detail with reference to age, sex, nature of poisoning, the time 
elapsed between consumption and reporting to the hospital, intent, 
symptomatology, duration of stay in the hospital and outcome.
All children who presented within 4 h received stomach wash 
and samples were sent for toxicological analysis. Blood counts, 
renal function test, liver function test, and coagulation profile were 
sent at admission in all cases. Continuous electrocardiographic 
(ECG) monitoring was done in all cases and ECG print taken at 
8 h intervals or earlier in the case of presence of any symptom. 
As most children at admission were either asymptomatic or only 
had minor symptoms arterial blood gas analysis was performed 
whenever an ECG abnormality was observed. For continuous 
variables mean and standard deviation was calculated, and the 
categorical variables were analyzed by Chi-square test.
RESULTS
Out of 146 poisoning cases, there were 17 cases of alleged 
rodenticide poisoning. Out of these, 9 were male and 8 were 
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female. 94% of the cases occurred in children <4 years of age 
including 2 in infancy. The only case of rodenticide poisoning 
in an older child occurred in a 7-years-old female child which 
was homicidal in nature. 4 cases (24%) presented within 1 h of 
ingestion, 11 cases (65%) presented within 6 h, 1 case presented 
after 24 h, and 1 after 4 days of ingestion. 12% received stomach 
wash from the referring hospital. In 10 cases (60%), the chemical 
ingested was identified as it was either brought by the care taker 
or detected in toxicological analysis of stomach wash content. 
5 (50%) contained zinc phosphide, 3 (30%) bromodiolone, and 
2 (20%) yellow phosphorous. Toxicological analysis of stomach 
wash content revealed the presence of toxin (zinc phosphide) 
in only 1 case. 12 of the 17 cases were symptomatic, of which 
5 (42%) had minor symptoms such as vomiting and abdominal 
pain and 7 (58%) had major symptoms including dysrhythmias, 
shock, coagulation abnormality, hepatic failure, and seizures.
About 47% of the children developed fever more than 100.4°C, 
12-72 h (mean 33 h) after ingestion that lasted for a maximum of 
48 h. 3 of the children had only a single spike of fever. 70% of 
children with cardiac manifestations had associated fever (p<0.1). 
Blood culture was negative in all cases. Leukocytosis with total 
count more than 12×109/L with lymphocytic predominance was 
present in 8 (47%) of patients at admission. 75% of patients with 
leukocytosis were clinically symptomatic. None of the patients 
in the asymptomatic group had leukocytosis (p<0.05). 5 (71%) 
patients with ECG changes had leukocytosis. Only 2 children 
had hypomagnesemia and both these children had ECG changes. 
Serum sodium, potassium, and calcium were normal in all 
children. Renal and liver function tests were normal in 16 out 
of 17 patients. Only one patient had renal and liver function 
derangement but had history of co-ingestion of paracetamol in 
toxic dose and presented on day 4 with fulminant hepatic failure.
ECG changes were observed in 7 (42%) cases. The mean 
time of onset of ECG changes was 19.7 h (range 9 to 36 h). In 
cases with ECG changes, all had more than 1 abnormal ECG 
findings. The 1st ECG change observed was transient intermittent 
bradycardia in 3 cases (42%) and transient sinus tachycardia in 
4 cases (58%). All the 7 cases subsequently developed other 
ECG changes including global T-wave inversion in 5 cases, 
QT prolongation in 2 cases, wide QRS complex, ST elevation, 
ventricular tachycardia, and junctional rhythm in 1 case each. 
ECG changes persisted for an average of 6.5 days (range 
3-10 days). Blood gas analysis was performed, in 6 out of 7 
cases with ECG changes and decompensated metabolic acidosis 
(pH<7.35 with HCo3<18) was present at the time of occurrence 
of ECG changes. Associated respiratory alkalosis was present in 
3 cases (50%). Metabolic acidosis persisted for an average of 6.4 
days (range 3-10 days).
Coagulation abnormality was found in only 2 cases (11.7%) of 
which, one had co-ingestion of paracetamol. In the another case, 
bromodiolone was accidentally ingested by an 11-month-old child 
who had prolonged prothrombin time (international normalized 
ratio> 10) and activated partial thromboplastin time (145 s), 6 h 
after ingestion, which was corrected with vitamin K and fresh 
frozen plasma. The baby did not have any clinical bleeding and her 
coagulation profile remained normal at follow-up 2 weeks later. 
Baby also developed lymphocytic leukocytosis and fever 24 h 
after admission which subsided 72 h later without antibiotics. She 
also had intermittent head sweating and global T-wave inversion 
in ECG which persisted for 2 weeks.
The overall mortality rate was 17.6%. It included 2 cases 
with cardiac toxicity and 1 case with fulminant hepatic failure. 
Cardiac causes of death included 1 case of refractory ventricular 
tachycardia and 1 case of sudden cardiac arrest. Among children 
with ECG changes, the mortality was 28.5%.
DISCUSSION
Rodenticide poisoning is common in India, and many parts 
of the world. 80% of single exposures to rodenticides involve 
children younger than 6 years [5]. In our study, majority of 
the patients (94%) were below 6 years of age. The cause of 
poisoning was accidental in 16 cases (94%) and homicidal in 
1 case. In the study on Zinc phosphide poisoning by Rahman 
et al. [6] 83.6% was suicidal and 16.4% accidental in intent. 
91% of patients included in that study were more than 10 years 
of age.
Only 23% cases presented within 1 h of ingestion probably 
signifying the fact that care takers are not really aware of the 
toxicity of rodenticides. Only 2 children out of 12 referred cases 
received stomach wash from the referring hospital. Rodenticides 
containing anticoagulants are the most common rodenticides 
in use in many parts of the world including the US where it 
accounts for 78% of rodenticides being used [5], but in our study 
Zinc phosphide was found to be the most common accounting 
for 50% of identified rodenticides, while superwarfarins 
accounted for 30%. The toxin could be identified in toxicological 
analysis of stomach wash contents in only 1case probably due 
to late presentation, prior stomach wash from a local hospital or 
inappropriate analytical methods.
Aluminum and zinc phosphides are highly toxic, low cost 
rodenticides. Upon ingestion of metal phosphides, phosphine gas 
(PH3) is released on contact with moisture or hydrochloric acid 
in the stomach [6]. Toxicity of phosphine is related to oxidant 
free radicals and associated inhibition of enzymes of metabolism, 
such as cytochrome c oxidase [7]. There are no specific antidotes 
for phosphide poisoning. Magnesium had been used for its 
membrane stabilizing, antiarrhythmic and antioxidant properties. 
There has been conflicting data on the use of magnesium sulfate. 
Many studies have shown a decrease in mortality and reversal of 
ECG changes with early use of magnesium sulfate [8,9], while 
Siwach et al. [10] in their study on serum and tissue magnesium 
levels in phosphide poisoning concluded that magnesium therapy 
did not have any impact on mortality. Metabolic acidosis has been 
documented in phosphide poisoning and sodium bicarbonate 
therapy has been found to be useful [10]. In the study by Abdel 
Rahman et al. [6] metabolic acidosis was present in 20% and 
respiratory alkalosis in 32% patients with phosphide poisoning. 
In our study, blood gas analysis was performed only in cases 
with ECG abnormalities. All cases with ECG abnormalities 
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had decompensated metabolic acidosis out of which three had 
associated respiratory alkalosis.
The major targets of PH3 poisoning in the human body are 
the lungs, heart, brain, gastrointestinal (GI) tract, kidney, and 
liver [2,10,11,12], In our study (Table 1) cardiac toxicity was 
the most common (41%), followed by GI symptoms (35%), and 
coagulopathy (11%). One case had fulminant hepatic failure. 
Severe hepatic dysfunction has been reported in Zinc phosphide 
poisoning [3,4,13]. Low incidence of renal involvement and liver 
involvement (6%) may be due to ingestion of lower quantity of 
toxin as most ingestions were accidental. GI symptoms (78%) 
have been reported as the most common symptom followed by 
respiratory symptoms (29%) in phosphide poisoning [5]. Brief 
episodes of fever and lymphocytic leukocytosis as symptoms 
have not been described in other studies. Phosphine produces 
an atmosphere of hypoxia and free radical stress by binding 
with cytochrome oxidase and by inhibiting catalase. Fever and 
leukocytosis may be a reactive response to free radical stress. 
Whether these symptoms are unique to children is not known as 
most studies on zinc and aluminum phosphide poisoning have not 
looked into hematological profile.
About 41% of patients had ECG changes or cardiovascular 
manifestations in our study (Figure. 1). Chugh et al. [2] also 
reported conduction disturbances and arrhythmia in 38% of 
patients with phosphide poisoning. In a study on ECG changes 
in aluminum phosphide poisoning by Soltaninejad et al. [3], the 
ECG changes or cardiovascular symptoms appeared between 3 
and 5 h after admission probably indicating massive intoxication 
as all were suicidal in intent. In our study, the average time 
interval between admission and ECG findings or cardiovascular 
manifestation was 19.7 h (range 9-36 h). Delayed onset in 
children may be due to ingestion of small quantity by children 
or slower effect of phosphine on target organs in children. In all 
cases with ECG changes there was associated metabolic acidosis 
which was treated with sodium bicarbonate therapy. Increased 
incidence of cardiac symptoms in our study probably indicates 
a higher susceptibility of heart to phosphine in young children.
Varying mortality rates have been reported ranging from 
25% [4] to 77% [2] in various metal phosphide poisoning studies. 
Lower mortality (17.6%) in our study may be due to a small quantity 
of accidental ingestion, early identification of minor ECG changes 
and supportive treatment with NaHCO3, intravenous magnesium 
sulfate, inj hydrocortisone, and inj carnitine in cases with ECG 
changes. Steroids have been recommended in Zinc phosphide 
poisoning due to its possible role in decreasing pulmonary injury 
and hypotension [14,15]. Chugh et al. [16] in their study on 
aluminum phosphide poisoning had also reported adrenocortical 
insufficiency. All children were given stomach wash with 2% 
NaHCO3 (to reduce gastric acid and production of phosphine) and 
1:10,000 potassium permanganate (to oxidize phosphine to less 
absorbable phosphide). In the 2 cases in which death occurred due 
to cardiac toxicity, one presented with transient bradycardia at 3 
h and developed resistant ventricular tachycardia unresponsive to 
amiodarone and shock and died at 10 h. The second case developed 
transient intermittent bradycardia at 12 h and sudden onset of 
respiratory distress and tachycardia at 30 h post ingestion due to 
pulmonary edema which responded to nasal continuous positive 
airway pressure. He went on to develop transient sinus tachycardia 
at 48 h with shock requiring inotropic support for 48 h and QRS 
widening with ST elevation was observed at 72 h. He developed 
sudden onset refractory bradycardia leading to cardiac arrest on day 
10 after admission. This child also had three episodes of seizure 
on day 5 of hospital stay. Transient, intermittent bradycardia as the 
initial rhythm abnormality was associated with increased risk of 
mortality (p<0.05). In both the cases of death since zinc phosphide 
was not identified in stomach wash, they did not receive steroids, 
sodium bicarbonate, and carnitine or IV magnesium. All other 
children with ECG changes received the supportive treatment for 
zinc phosphide poisoning.
The child with a history of accidental ingestion of bromodiolone 
had abnormal coagulation profile at 6 h post ingestion. The early 
appearance of coagulation abnormality probably signifies greater 
sensitivity of young infants to bromodiolone. Occurrence of 
ECG changes in the child with bromodiolone ingestion probably 
indicates undisclosed combination of rodenticides for better 
efficacy by manufactures or shopkeepers. Time to stomach wash 
did not have any impact on outcome, probably it is the quantity 
ingested which is more important as has been shown in other 
studies [13,17]. The better outcome in patients who presented 
early [18] and received GI decontamination with sodium 
bicarbonate has also been described [2]. The small sample size 
is a limitation of this study. Blood gas analysis was performed 
Table 1: Analysis of symptoms
Symptoms n (%)
Vomiting 6 (35)
ECG changes 7 (41)
Coagulopathy 2 (12)
Liver failure 1 (6)
Seizure 1 (6)
Fever 8 (47)
Head sweating 2 (12)




Figure 1: Electrocardiographic changes observed in rodenticide 
poisoning
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only on observing an ECG change, whether metabolic acidosis 
was present at admission itself in these children is not known. 
Further studies with larger sample size will help us elucidate the 
toxidrome of rodenticide poisoning in children more clearly.
CONCLUSION
Zinc phosphide has become the most common chemical being 
used as domestic rodenticide. Transient heart rate abnormalities, 
fever, leukocytosis, and metabolic acidosis are early markers of 
toxicity, and they should looked for in all cases. All children with 
rodenticide poisoning should be observed with continuous ECG 
monitoring for 1st 48 h. Initial manifestations in children are more 
subtle compared to adults probably due to ingestion of lower 
quantities. Cardiac arrhythmia was the most common cause of 
death. General public, medical, and paramedical personnel should 
be made aware of the toxic nature of rodenticides.
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